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Abstract: The identification of disease-associated genes has recently gathered much attention for 
uncovering disease complex mechanisms that could lead to new insights into the treatment of diseases. 
For exploring disease-susceptible genes, not only experimental approaches such as genome-wide 
association studies (GWAS) have been used, but also computational methods. Since experimental 
approaches are both time-consuming and expensive, numerous studies have utilized computational 
techniques to explore disease genes. These methods use various biological data sources and known 
disease genes to prioritize disease candidate genes. In this paper, we propose a gene prioritization method 
(NRSSPrioritize), which benefits from both local and global measures of a protein-protein interaction 
(PPI) network and also from disease similarity knowledge to suggest candidate genes for colorectal 
cancer (CRC) susceptibility. Network Propagation, Random Walk with Restart, and Shortest Paths are 
three network analysis tools that are applied to a PPI network for the purpose of scoring candidate genes. 
Also, by looking through diseases with similar symptoms to CRC and obtaining their causing genes, 
candidate genes are scored in a different way. Finally, to integrate these four different scoring schemes, 
Technique for Order Preference by Similarity to Ideal Solution (TOPSIS) and Analytic Network Process 
(ANP) methods are applied to obtain appropriate weights for the above four quantified measures and the 
weighted summation of these measures are used to calculate the final score of each candidate gene. 
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NRSSPrioritize was validated by cross-validation analysis and its results were compared with other 
prioritization tools, which gave the best performance when using our proposed method. 
Keywords: Gene prioritization, Protein-protein interaction network, Symptoms, Colorectal cancer. 
 
1. Introduction 
One of the most important challenges in disease treatment is the identification of causing genes that help us to 
design medical protocols. Genome-Wide Association Studies (GWAS) are new techniques for the identification of 
chromosomal intervals containing suspected disease related genes. These studies search for the genomes of single 
nucleotide polymorphisms (SNPs) that are not rare. However GWAS studies are not very accurate for detecting the 
exact gene related to a disease because they suggest hundreds or thousands of genes. Investigating all the genes 
suggested by GWAS in order to find the desired gene using experimental methods is very expensive and time 
consuming. Computational methods prioritize these genes and help us to focus on a smaller set of genes. For this 
purpose, computational methods utilize disease genes that are suggested experimentally as seed genes and 
prognosticate candidate genes for further studies. They use various data to solve the problem and some of them 
compose multiple data source information.  
Related genes for the same or a homologous disease tend to have interactions with each other in the PPI network (1). 
So the protein-protein interaction (PPI) network has become one of the most powerful sources in these studies, and 
this information has recently been provided in network structures. Integrating the PPI network with other biological 
data may lead to the discovery of new disease-causing genes. Some studies use local features of the PPI network, 
such as molecular triangulation (2), shortest path (SP) (3), and direct neighbors (4) to identify candidate genes. 
Some other studies such as Random Walk with Restart (RWR) (5) and Network Propagation (NP) (6) relay on 
global network information. The results of local algorithms are more vulnerable because they do not consider 
indirect functional relationships and so only consider direct interactions (7). On the other hand, global algorithms 
rely on the overall relationship between the disease gene and the other genes of the PPI network. Although they do 
not consider genes with poor connections and outliers, they have displayed a better performance than local methods 
(8). 
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Biological resources are very prone to containing noise. However, prioritization based on the quality of raw data and 
the composition of various heterogeneous data sources is helpful to overcome this disadvantage. DIR (9), ToppGene 
(10), CANDID (11), Endeavor (12) and MetaRanker (13) are examples of these hybrid methods.  
In this approach, we propose a novel method called NRSSPrioritize (the acronym for the combination of Network 
Propagation, Random Walk with Restart, Shortest Paths, and Symptom similarity knowledge for genes Prioritize), 
which compares disease similarity knowledge with local and global network information to qualify the performance 
of the prioritization process and overcome the disadvantages of the aforementioned methods. In our method, PPI 
network genes are scored separately by using NP, RWR and SP methods. Also, we use disease symptom similarity 
information to score genes. Then, we calculate the final score as a weighted summation of scores. The Multiple 
Attribute Decision-making (MADM) (14) method was applied to calculate the weight of weighted summation. We 
applied NRSSPrioritize to Colorectal Cancer (CRC) datasets, that disease being one of the leading causes of death in 
the world (15, 16). The evaluation proves that using local and global network information in combination with other 
disease related knowledge leads to more accurate results in comparison to previous methods. 
 
2. Material and Methods 
2.1. Protein-Protein interaction network  
We used the PPI network, which represents interaction between proteins. Information regarding to the PPI network 
is gathered from previous research information (17). Protein interactions in the PPI network are extracted from 
several databases and each interaction is weighted according to two criteria: 
 The interaction was given more weight if it was reported in more studies. 
 The weight of interaction that was observed in the large scale experiment is heavier than the other one. 
 
This network is undirected. Our network contains 22997 nodes, which are constructed from 89 subgraphs. Each 
node represents one protein and the edges are interactions between proteins. There are 10103 isolated nodes in the 
network that do not have any useful interactional information. So we removed them, and thus 12894 nodes 
remained. We used the DisGeNET database (18) to extract CRC genes. The DisGeNET database contains 2394 
CRC genes. 1121 genes were found in the PPI network and mapped as seed genes. 
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2.2. Genes scores calculation (NRSSPrioritize steps) 
We applied NP, RWR, and SP algorithms separately on the PPI network to rank genes. Also, we employed disease 
similarity information in our scoring. The Dijkstra (19) algorithm was used to calculate the lengths and weight of 
shortest paths between the seed genes and the other genes. Then we divided the median of the weights of the 
shortest paths to the seeds to the average of the shortest paths length for each non-seed node. Obviously, a gene with 
a higher shortest path weight median and a smaller average length is more likely to be associated with disease (20). 
RWR calculates the proximity between nodes in the network (5). It repeatedly studies the global structure of the PPI 
network to approximate the relationship rate between nodes. RWR starts with a seed gene. In each step, it is faced 
with two choices; going to a neighbor of the current node or moving to one of the seed genes. It calculates node 
scores according to the following equation: 
𝑦𝑡+1 = (1−∝)𝑊𝑦𝑡+∝ 𝑦0 (1) 
Here 𝑊 is the adjacency matrix in which its columns are normalized. 𝑦0 is a probability vector of the nodes at the 
first step. We assigned equal values to seed genes, and other gene probabilities are set to zero. 𝑦𝑡 represents a 
probability of all the nodes at step 𝑡. Also, ∝ is a fixed parameter, which is called the restarting probability and it 
determines the probability of restarting random walk from seed genes (1−∝ is probability of going to a neighbor). 
In this study, the value of ∝ value is 0.15. This algorithm iterates repeats until the difference between y𝑡 and y𝑡+1 
becomes less than 10−6 (5). 
NP uses network flow propagation to prioritize genes. It simulates an information pump that emanates at the seeds. 
Its idea is very similar to the RWR algorithm with one difference. In the NP algorithm, output and input flows of 
nodes are both normalized (rows and columns are normalized) (6). After applying these algorithms, three scores are 
assigned to each non-seed gene. 
It is rational to suppose that similar phenotypes have a common causing gene (21, 22), and it has also been proved 
that the causing gene of diseases with similar symptoms have a shared interacting gene (23). So, we used the 
Human Symptoms Disease Network (HSDN) (23) to find diseases with similar symptoms to CRC. In this network, 
nodes represent diseases and the edges are the symptom similarities between them. In the Human Symptoms 
Disease Network, the subscription rate between diseases and the common MeSH terms between diseases are used 
to weight the similarity edges. Here, we selected ten top similar diseases to CRC (Fig. 1) and we extracted their 
causing genes from the DisGeNet database. We calculated the intersection between the causing genes of these top 
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similar diseases and assigned these scores to each non-seed gene. For example, a gene that is associated with one 
disease, earns a score of one. 
 
 
Figure 1. Top 10 similar diseases to CRC according to their symptoms were obtained from HSDN and their causing genes 
were extracted from the DisGeNet database. We calculated the intersection between the causing genes of these top 
similar diseases and assigned this score to each non-seed gene 
 
2.3. Combining scores of each gene with MADM 
In the previous steps, the genes received four different scores. Then we used the weighted summation to calculate 
the final score of each gene. The MADM technique was applied to calculate the weight of each step. In MADM, 
there are several possible alternatives that are evaluated according to some criteria, and they are then ranked. In this 
approach, we considered disease symptom similarity, RWR, NP and SP steps as alternatives that are evaluated by 
leave-one-out cross-validation criteria. In other words, the result of each step was assessed in leave-one-out cross-
validation analysis and some criteria were measured according to this analysis to definitively weight each step (Fig. 
2).  
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Figure 2. NP, RWR, SP and symptom similarity scores were calculated for each gene. We used the weighted summation to 
calculate the final score of each gene. So, MADM was applied to obtain the weight for each step. Four steps are 
considered as alternatives that are evaluated by criteria. For this reason, the result of each step was assessed in leave-
one-out cross-validation analysis and AUC, MRR, AR, 1% and 5% criteria were measured according to this analysis. 
Finally, a weight was assigned to each step and was then ranked. 
 
In leave-one-out cross-validation, each seed gene is removed from a seed gene set (target gene) and an artificial 
linkage interval is constructed on its 99 chromosomal neighbors, which are obtained from the UCSC database (24). 
These 99 genes and the target gene were then considered to be the candidate set and the remaining seed genes made 
up the new seed set. We then applied our algorithm to this new candidate set, from which their genes were ranked 
according to the new seed gene set (Fig. 3). 
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Figure 3. Leave-one-out cross-validation analysis 
In each step, one seed gene was removed from the seed genes set (called terget gene) and was considered 
with 99 chromosomal neighbors as a new candidate set. This new candidate set was ranked using the 
prioritization method according to the seed genes set information. Finally the target gene position was 
assessed in a ranked list. 
 
 
A Receiver Operating Characteristic (ROC) curve is drawn to show the performance of a specific method with plot 
sensitivity versus 1-specificity. Also, an Area Under Curve (AUC) measure is calculated for each curve. Here, 
sensitivity is the percentage of disease genes that are ranked above a specific (k) threshold, and specificity defines 
the percentage of all genes ranked below the threshold (k). Also, Mean Reciprocal Rank (MRR) is obtained by using 
the following equation: 
𝑀𝑅𝑅 =
1
𝑄
∑
1
𝑟𝑎𝑛𝑘𝑖
𝑄
𝑖=1
 
(2) 
Here 𝑟𝑎𝑛𝑘𝑖  is the rank of the target gene in the ith candidate set and 𝑄 is the count of candidate gene sets. The 
other measure is an average rank (AR), which is the average rank of the target seeds in their related candidate sets. 
1% and 5% are also the other criteria that represent the percentage of target genes in the top 1% and 5% of 
candidate sets. All these measures are reported for NP, RWR, SP and disease similarity step in Table 1. 
After calculating AUC, AR, MRR, 1% and 5% measures, we applied the Analytic Network Process (ANP) (25) 
method. The ANP considers the relationship and feedback between criteria in the whole system in order to compare 
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them. So the network structure was constructed as you can see in Fig. 4. The following order was utilized to 
compare the criteria and to weigh them. AUC and MRR globally assess results and thus we gave more importance 
to them. 
𝐴𝑈𝐶 > 𝑀𝑅𝑅 > 𝐴𝑅 > 1% > 5% 
 
Then, these criteria weights was used in the Technique for Order Preference by Similarity to Ideal Solution 
(TOPSIS) (26) to investigate the RWR, NP, SP and symptom similarity steps (alternatives) according to criteria. The 
TOPSIS method is based on the concept that the best alternatives should have the shortest distance from the 
positive-ideal solution and the longest distance from the negative-ideal solution. This means that, positive and 
negative ideal solutions are built to compare the alternatives against each other and to weigh them. We used these 
weights in the weighted summation to rank non-seed genes. Notably, other MADM methods are examined and the 
best result is found using hybrid TOPSIS-ANP, such as analytic hierarchy process (AHP) (27), Fuzzy TOPSIS 
(FTOPSIS) (28), Fuzzy AHP (FAHP) (29) and FTOPSIS-FAHP methods.  
 
Table 1. Performance measures for each step of NRSSPrioritize. 
 Methods AUC MRR AR 1% 5% 
NP 0.91 0.25 9.3 0.12 0.40 
RWR 0.90 0.25 10 0.12 0.40 
SP 0.91 0.22 9.7 0.08 0.32 
Symptom similarity 0.88 0.34 11.88 0.18 0.48 
 
 
 
 
 
Figure 4. Network structure for performance criteria in the ANP method. 
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For a more accurate conclusion, we applied the Weighted Discounted Rating System (WDSR) (30) and the N-
dimensional Order Statistics (NDOS, used in the Endeavour method) (12) to integrate the outcomes of the four 
aforementioned steps. These methods compose multiple ranked lists to obtain one rank. We evaluated their 
performance using leave-one-out cross-validation. Fig. 5 illustrates the ROC curve for each method. As can be seen, 
weighted summation with TOPSIS-ANP displayed a better performance than WDRS and NDOS by a significant 
margin. 
 
 
Figure 5. Performance comparison for Heterogeneous data composition methods 
Each gene was assigned four scores in our approach and we applied hybrid TOPSIS-ANP to calculate the weight of each 
score and then obtained the final score by weighted sumation. Also, NDOS and DRS were examined and compared with 
our result for more reliability. 
 
 
3. Results and discussion 
In this paper, we proposed the NRSSPrioritize method, which integrates protein complex and disease similarity 
knowledge to utilize the benefits of both. Diseases with similar symptoms probably have common causing genes 
(21, 22), and also disease related proteins tend to have interactions with each other(1). There are 12894 genes in the 
PPI network, of which 1121 genes were marked as disease genes (seed genes) and we detected 91% of seed genes 
(1025 seed genes) in one subgraph of the PPI network. This observation reinforces the hypothesis that disease 
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assosiated genes tend to have interaction with each other in the protein levels. Additionally, we applied the Mann–
Whitney U-test to the GSE32323 dataset, which was obtained from the GEO database (31) and observed that 449 of 
the seeds have significant differential expressions. NP and RWR algorithms utilitize network global information to 
calculate the proximity between disease genes and other genes, and the SP algorithm relies on local network 
characteristics. These three methods are separately applied to the PPI network in order to conquer the disadvantage 
of local and global methods. İt may seem that the simultaneous usage of  NP and RWR is useless, but we observed 
that comparing their scores overcame all performance measures. Finally, all aformentioned information was 
integrated with weighted summation based on the hybrid TOPSIS-ANP method. NRSSPrioritize was evaluated and 
compared to other prioritization tools such as Endeavour, ToppGene and DIR, which use multiple data sources to 
prioritize disease candidate genes. We used ROC analysis to compare various methods (shown in Fig. 6).  
 
Figure 6.Comparison of priortization methods 
A performance comparison has been carried out for NRSSPrioritize, Endeavour, ToppGene and DIR prioritization 
methods in a leave-one-out cross-validation for CRC causing genes. The figure shows sensitivity versus 1-specificity 
with diffrent values of k threshold. 
 
Also, AUC of each curve is calculated for a more accurate comparison. NRSSPrioritize produced the highest AUC 
with 0.93 and DIR, Endeavour and ToppGene had  0.91, 0.76, and 0.70 AUC values respectively. The MRR for all 
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methods are shown in Fig. 7. Our method achived a 0.42 MRR value, which is higher than the other methods. 
Additionally in 26% of the cases, NRSSPrioritize ranked the target gene as the first of a candidate gene set and in 
54% of the cases, target genes were in a 1 to 5 ranking of the candidate sets. The AR of our method was the lowest 
amon for all examined algorithms. AR, 1% and 5% measures are shown in Table 2 for all prioritization methods. 
Overall, all measures showed that our method displayed a better performance in comparison to the other previously 
examined algorithms.  
 
 
 
Figure 7. The MRR value is illustrated for each prioritization method. Our approach ’s MMR is the highest. 
 
4. Conclusion 
We applied RWR, NP and SP algorithm separately to the PPI network. Then, we scored genes based on disease 
similarity knowledge. We combined these four scores by weighted summation. We used the TOPSIS-ANP MADM 
method to calculate the weight of each score. With this strategy, we combined protein complexity information with 
specialized disease knowledge. Also, NP, SP and RWR are network-based methods and using them at same time led 
to decreasing the noise of the PPI network. Our achievements prove that considering various characteristics of genes 
is important in disease gene identification and that we can overcome the disadvantages of existing methods by 
combining different types of knowledge. 
 
Table 2. AR, 1% and 5% measure values for our method and other prioritization methods. 
 
                         Methods AR 1% 5% 
NRSSPrioritizer 7.1 0.26 0.54 
Endeavour 10.5 0.10 0.40 
TopGene 10.94 0.14 0.34 
DIR 9.6 0.18 0.38 
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